/PRNewswire/ Prestige Biopharma Limited (KRX: 950210, hereafter referred to as "Prestige") and Intas Pharmaceuticals Limited (hereafter referred to as.
/PRNewswire/ EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, and Accord BioPharma, the U.S. specialty.
Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to Commercialize ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe - read this article along with other careers information, tips and advice on BioSpace